Date: 26th February 2023
Title: CLL Management 2023 - Year in Review

George follows, United Kingdom


Hani Osman, United Arab Emirates


Ihab El-Hemaidi, Saudi Arabia


Mahmoud Marashi, United Arab Emirates


Feras Al Fraih, Saudi Arabia

Date: 6th November 2022
Title: Applying guideline updates and real-world experience in CLL

Khalil Al Farsi, Oman


Ruba Taha, Qatar


Susan M. O'Brien, United States


Ayman Al Hejazi, Saudi Arabia

Date: 25th September 2022
Title: EHA & ASCO updates in B-Cell malignancies

Alfadel AL Shaibani, Saudi Arabia


Davide Rossi, Switzerland


Faraz Khan, United Arab Emirates


Ramesh Pandita, Kuwait


Ahmad Absi, Saudi Arabia

Date: 26th June 2022
Title: Precision approach for CLL treatment

Ahmad Alhuraiji, Kuwait


Aamer Aleem, Saudi Arabia


Krish Patel, United States


Shabeeha Rana, United Arab Emirates


Amal Al-Beihany, Saudi Arabia

Date: 22nd May 2022
Title: High-risk CLL in the era of Novel Agents

Ayman Al Hejazi, Saudi Arabia


Wojciech Jurczak, Poland


Iman Alhazmi, Saudi Arabia


Amar Lal, United Arab Emirates


Arif Alam, United Arab Emirates

Date: 17th April 2022
Title: Updates in Management of MCL

Mustaqeem Siddiqui, United Arab Emirates


Michael Wang, United States


Salem Alshemmari, Kuwait


Ghazi Alotaibi, Saudi Arabia


Abdulaziz Hamadah, Kuwait

Date: 27th March 2022
Title: Adverse Events burden and management in CLL treatments

Cyrus Khan, United States


Hassan Al Jasim, Saudi Arabia


Husni Al Hateeti, United Arab Emirates


Musa Al Zahrani, Saudi Arabia


Amar Lal, United Arab Emirates

Date: 27th Feb 2022
Title: BTKi review in management of CLL

Abdulkareem Algarni, Saudi Arabia


George Follows, United Kingdom


Hany Osman, United Arab Emirates


Mahmoud Marashi, United Arab Emirates


Ahmad Absi, Saudi Arabia